Filing Details

Accession Number:
0001562180-17-000234
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-13 15:51:58
Reporting Period:
2017-01-13
Filing Date:
2017-01-13
Accepted Time:
2017-01-13 15:51:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1597553 Sage Therapeutics Inc. SAGE () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1304815 Kimi Iguchi C/O Sage Therapeutics, Inc.
215 First Street
Cambridge MA 02142
Cfo, Secretary And Treasurer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-01-13 10,000 $53.92 66,498 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. The sales reported on this Form 4 were effected pursuant to a trading plan adopted pursuant to Rule 10b5-1 under the Securities Exchange Act of 1934, as amended.
  2. This transaction was executed in multiple trades at prices ranging from $53.72 USD to $54.33 USD; the price reported above reflects the weighted average sale price.
  3. These shares include prior ESPP purchases.